Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.05 USD | +1.30% | -1.56% | +19.08% |
05-13 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Sales 2024 * | 138M 188M | Sales 2025 * | 157M 215M | Capitalization | 1.53B 2.08B |
---|---|---|---|---|---|
Net income 2024 * | 92M 125M | Net income 2025 * | 50M 68.13M | EV / Sales 2024 * | 11.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 9.7 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
26.4
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.7% |
Latest transcript on Ligand Pharmaceuticals Incorporated
1 day | +1.30% | ||
1 week | -1.56% | ||
1 month | +21.69% | ||
3 months | +7.18% | ||
6 months | +45.86% | ||
Current year | +19.08% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 63 | 07-02-28 |
Octavio Espinoza
DFI | Director of Finance/CFO | 53 | 22-10-31 |
President | 49 | 15-08-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Kozarich
CHM | Chairman | 74 | 03-02-28 |
John LaMattina
BRD | Director/Board Member | 74 | 11-01-31 |
Stephen Sabba
BRD | Director/Board Member | 64 | 08-08-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 25 M€ | -2.35% | - | |
0.14% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 85.05 | +1.30% | 122,260 |
24-05-30 | 83.96 | -1.17% | 152,442 |
24-05-29 | 84.95 | -1.20% | 107,499 |
24-05-28 | 85.98 | -0.49% | 108,065 |
24-05-24 | 86.4 | +1.75% | 160,612 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.08% | 1.53B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- LGND Stock